TABLE 2.
Australia | Belgium1 | Canada | Germany | France | UK | US | Austria | Switzerland | |
BMI (kg/m2) | >25 (MR) >35 (HR) |
>25 | ≥30 | ≥30 | ≥25 | >30 | ≥25 + additional risk factor below | “Adiposity” | >25 |
Age (years) | ≥40 (HR) | ≥35 | ≥35 | ≥45 | ≥35 | >45 | >25 | ||
History of GDM | ✓ (HR) | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
Family history of diabetes (first-degree relative) | ✓ (HR) | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | |
Prediabetes | ✓ | ✓ | ✓ | ✓ | |||||
Ethnicity | Aboriginal, Asian, Middle Eastern, Black African (MR) | ✓ | Aboriginal, Hispanic, Asian, African | Asian, Hispanic (*Middle Eastern, *African) | South Asian, Black, Caribbean, Middle Eastern | African American, Latino, Native American, Asian American, Pacific Islander | Specific ethnic groups (e.g., Asian) | Specific ethnic groups: Asian, Latin American | |
History of macrosomic baby | ✓ (HR) | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
Current macrosomic baby | ✓ | ✓* | † | ✓ | |||||
History of fetal malformation | ✓* | ✓ | |||||||
History of stillbirth | ✓ | ||||||||
Current polyhydramnios | ✓ | ✓* | † | ||||||
Repeated abortion (≥3) | ✓* | ✓ | |||||||
History of obstetric complications | ✓ | ||||||||
Polycystic ovarian syndrome | ✓ (HR) | ✓ | ✓ | ✓ | ✓ | ||||
Steroid use | ✓ (HR) | ✓ | ✓ | ||||||
Antipsychotic use | ✓ (HR) | ✓ | |||||||
Hypertension | ✓ (HR) | ✓ | ✓ | ✓ | |||||
Physical inactivity | ✓ | ✓ | |||||||
Dyslipidemia, hypertriglyceridemia | ✓ | ✓ | ✓ | ||||||
History of cardiovascular disease | ✓ | ✓ | ✓ | ||||||
Glucosuria | ✓ | ||||||||
Metabolic syndrome | ✓ | ||||||||
Diabetes symptoms | ✓ |
HR, high risk; MR, moderate risk.
Mentioned in text but not in flowchart.
Not listed as specific risk factor but requires screening for GDM.
GGOLFB, Groupement des Gynécologues Obstétricien de Langue Française de Belgique.